Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

In vivo microvascular and macrovascular endothelial function is not associated with circulating dimethylarginines in patients with rheumatoid arthritis: a prospective analysis of the DRACCO cohort.

Dimitroulas T, Sandoo A, Hodson J, Smith JP, Kitas GD.

Scand J Clin Lab Invest. 2016 Jul;76(4):331-7. doi: 10.1080/00365513.2016.1177852. Epub 2016 May 11.

PMID:
27166512
2.

Associations between asymmetric dimethylarginine, homocysteine, and the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism (rs1801133) in rheumatoid arthritis.

Dimitroulas T, Sandoo A, Hodson J, Smith J, Douglas KM, Kitas GD.

Scand J Rheumatol. 2016 Jul;45(4):267-73. doi: 10.3109/03009742.2015.1086433. Epub 2015 Nov 24.

PMID:
26599798
3.

Symmetric Dimethylarginine Is Not Associated with Cumulative Inflammatory Load or Classical Cardiovascular Risk Factors in Rheumatoid Arthritis: A 6-Year Follow-Up Study.

Dimitroulas T, Hodson J, Sandoo A, Smith JP, Douglas KM, Kitas GD.

Mediators Inflamm. 2015;2015:796562. doi: 10.1155/2015/796562. Epub 2015 Oct 12.

4.

The impact of abatacept treatment on the vasculature in patients with rheumatoid arthritis.

Sandoo A, Kitas GD.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4):589. Epub 2015 Jun 29. No abstract available.

PMID:
26121184
5.

Breast cancer therapy and cardiovascular risk: focus on trastuzumab.

Sandoo A, Kitas GD, Carmichael AR.

Vasc Health Risk Manag. 2015 Apr 7;11:223-8. doi: 10.2147/VHRM.S69641. eCollection 2015. Review.

6.

Symmetric dimethylarginine (SDMA) serum levels in rheumatoid arthritis: correlations with insulin resistance and disease activity scores.

Dimitroulas T, Hodson J, Sandoo A, Smith J, Kitas GD.

Amino Acids. 2015 Sep;47(9):1995-2004. doi: 10.1007/s00726-015-1953-x. Epub 2015 Mar 13.

PMID:
25772817
7.

A methodological approach to non-invasive assessments of vascular function and morphology.

Sandoo A, Kitas GD.

J Vis Exp. 2015 Feb 7;(96). doi: 10.3791/52339.

8.

Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms.

Arts EE, Popa CD, Den Broeder AA, Donders R, Sandoo A, Toms T, Rollefstad S, Ikdahl E, Semb AG, Kitas GD, Van Riel PL, Fransen J.

Ann Rheum Dis. 2016 Apr;75(4):674-80. doi: 10.1136/annrheumdis-2014-206879. Epub 2015 Feb 17.

PMID:
25691119
9.

Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis.

Dimitroulas T, Sandoo A, Hodson J, Smith J, Panoulas VF, Kitas GD.

Atherosclerosis. 2014 Nov;237(1):38-44. doi: 10.1016/j.atherosclerosis.2014.07.033. Epub 2014 Aug 27.

PMID:
25194333
10.

Cumulative inflammation associates with asymmetric dimethylarginine in rheumatoid arthritis: a 6 year follow-up study.

Sandoo A, Dimitroulas T, Hodson J, Smith JP, Douglas KM, Kitas GD.

Rheumatology (Oxford). 2015 Jul;54(7):1145-52. doi: 10.1093/rheumatology/keu349. Epub 2014 Sep 3.

11.

The relationship between cardiovascular disease risk prediction scores and vascular function and morphology in rheumatoid arthritis.

Sandoo A, Chanchlani N, Hodson J, Smith JP, Douglas KM, Kitas GD.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6):914-21. Epub 2014 Aug 15.

PMID:
25152090
12.

Endothelial dysfunction as a determinant of trastuzumab-mediated cardiotoxicity in patients with breast cancer.

Sandoo A, Kitas GD, Carmichael AR.

Anticancer Res. 2014 Mar;34(3):1147-51. Review.

PMID:
24596352
13.

Asymmetric dimethylarginine is not associated with subendocardial viability ratio in Rheumatoid Arthritis.

Dimitroulas T, Sandoo A, Smith JP, Kitas GD.

Int J Cardiol. 2014 Mar 1;172(1):285-6. doi: 10.1016/j.ijcard.2013.12.235. Epub 2014 Jan 10. No abstract available.

PMID:
24447745
14.
15.

Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden.

Panoulas VF, Toms TE, Douglas KM, Sandoo A, Metsios GS, Stavropoulos-Kalinoglou A, Kitas GD.

Rheumatology (Oxford). 2014 Jan;53(1):131-7. doi: 10.1093/rheumatology/ket338. Epub 2013 Oct 3.

16.
17.

Individualised exercise improves endothelial function in patients with rheumatoid arthritis.

Metsios GS, Stavropoulos-Kalinoglou A, Veldhuijzen van Zanten JJ, Nightingale P, Sandoo A, Dimitroulas T, Kitas GD, Koutedakis Y.

Ann Rheum Dis. 2014 Apr;73(4):748-51. doi: 10.1136/annrheumdis-2013-203291. Epub 2013 Jul 31.

PMID:
23904472
18.

Predictors of asymmetric dimethylarginine levels in patients with rheumatoid arthritis: the role of insulin resistance.

Dimitroulas T, Sandoo A, Veldhuijzen van Zanten JJ, Smith JP, Hodson J, Metsios GS, Stavropoulos-Kalinoglou A, Kitas GD.

Scand J Rheumatol. 2013;42(3):176-81. doi: 10.3109/03009742.2012.747627. Epub 2013 Jan 14.

PMID:
23311682
19.

Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases.

Dimitroulas T, Sandoo A, Kitas GD.

Int J Mol Sci. 2012 Sep 26;13(10):12315-35. doi: 10.3390/ijms131012315. Review.

20.

The role of inflammation, the autonomic nervous system and classical cardiovascular disease risk factors on subendocardial viability ratio in patients with RA: a cross-sectional and longitudinal study.

Sandoo A, Protogerou AD, Hodson J, Smith JP, Zampeli E, Sfikakis PP, Kitas GD.

Arthritis Res Ther. 2012 Nov 28;14(6):R258. doi: 10.1186/ar4103.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk